WAM
IPXL

Wolverine Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Wolverine Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,480
Closed -$106K – 1804
2015
Q4 		$106K Buy
+2,480
New +$99.1K ﹤0.01% 993

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wolverine Asset Management's IPXL Position: Q1 2016 in Review

Wolverine Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2016, closing a stake of 2,480 shares — an estimated $106K sold.

Wolverine Asset Management first reported a position in IPXL in Q4 2015 and held it in 1 quarter. The position peaked at $106K in Q4 2015. 194 funds tracked by Wall St. Rank hold IPXL as of Q1 2016.

  • Wolverine Asset Management reported no remaining Impax Laboratories, Inc. position as of Q1 2016 after selling out during the quarter.
  • Wolverine Asset Management sold 2,480 Impax Laboratories, Inc. shares in Q1 2016, an estimated $106K.
  • Wolverine Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2015 and held it in 1 quarter.
  • Wolverine Asset Management's Impax Laboratories, Inc. position peaked at $106K in Q4 2015.
  • 194 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2016.

Based on Wolverine Asset Management's 13F filing for Q1 2016, filed 16 May 2016.